Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Stanford Biosciences (5T32-GM11999505)
- National Institutes of Health (5T32-GM11999505)
- National Institutes of Health (2P30CA124435-16)
- National Institutes of Health (R35CA283888)
- National Institutes of Health (R0CA263500-01)
- National Institutes of Health (2P01CA217959-06A1)
- European Molecular Biology Organization (ALTF 405-2023)
- Fundación Ramón Areces
- St. Baldrick's Foundation
- National Science Foundation (2146755)
- Mark Foundation For Cancer Research
- CRIS Cancer Foundation
- Virginia and D.K. Ludwig Fund for Cancer Research
- Parker Institute for Cancer Immunotherapy
This publication has 97 references indexed in Scilit:
- Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceCancer Cell, 2022
- Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumorCancer Immunology, Immunotherapy, 2022
- An NK-like CAR T cell transition in CAR T cell dysfunctionCell, 2021
- Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2Journal of Leukocyte Biology, 2021
- The role of exhaustion in CAR T cell therapyCancer Cell, 2021
- The metalloproteinase ADAM10 requires its activity to sustain surface expressionCellular and Molecular Life Sciences, 2020
- Analysis of CAR-Mediated Tonic Signaling2019
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell ResponsesCell, 2018
- Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Cell, 2017
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch ReceptorsCell, 2016